Dendritic cell reconstitution following autologous stem cell transplant with GM-CSF support for multiple myeloma

被引：0
|
作者：
Schlueter, Annette J. [1 ]
Glasgow, Judith K. [1 ]
Wilke, Werner [1 ]
Marietta, Jacquie R. [1 ]
Hohl, Raymond J. [1 ]
Carter, Thomas H. [1 ]
Gingrich, Roger D. [1 ]
Magalhaes-Silverman, Margarida D. [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.951.951
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
951
引用
收藏
页码：289A / 290A
页数：2
相关论文
共 50 条
  • [31] Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
    Wood, Kevin
    Giralt, Sergio A.
    Koehne, Guenther
    Chung, David
    Hassoun, Hani
    Lendvai, Nikoletta
    Lesokhin, Alexander
    Hoover, Elizabeth
    Devlin, Sean
    Landau, Heather
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S192 - S192
  • [32] Fractionated Stem Cell Infusions for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant
    Wood, Kevin
    Giralt, Sergio A.
    Koehne, Guenther
    Chung, David
    Lendvai, Nikoletta
    Hassoun, Hani
    Lesokhin, Alex
    Hoover, Elizabeth
    Devlin, Sean
    Landau, Heather
    BLOOD, 2012, 120 (21)
  • [33] LONG TERM OUTCOME OF RENAL FAILURE IN MULTIPLE MYELOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT
    Glavey, Siobhan V.
    Gertz, Morie A.
    Dispenzieri, Angela
    Kumar, Shaji
    Buadi, Francis
    Lacy, Martha
    Hayman, Suzanne R.
    Dingli, David
    Hogan, William J.
    Gastineau, Dennis A.
    Leung, Nelson
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A41 - A41
  • [34] A double blinded randomized trial comparing a new GM-CSF, LEUCOTROPIN™, and LEUCOMAX® for myeloid reconstitution following autologous peripheral blood stem cell transplantation (APBSCT).
    Sinclair, CJD
    Bence-Bruckler, I
    Turner, AR
    Bredeson, C
    Stewart, DA
    Poynton, CH
    Hatton, CSR
    Couban, S
    Howson-Jan, K
    Marcus, R
    Genereux, M
    Ede, M
    Stewart, DI
    BLOOD, 2002, 100 (11) : 866A - 866A
  • [35] The Effect of Maintenance Therapy Following Salvage Autologous Stem Cell Transplant in Multiple Myeloma Patients
    Wang, Brandon B.
    Fiala, Mark A.
    Schroeder, Mark A.
    Wildes, Tanya
    Ghobadi, Armin
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    BLOOD, 2018, 132
  • [36] The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma
    Salafian, Kiarash
    Mazimba, Christine
    Volodin, Leonid
    Varadarajan, Indumathy
    Pilehvari, Asal
    You, Wen
    Knio, Ziyad O.
    Ballen, Karen
    BONE MARROW TRANSPLANTATION, 2024, 59 (04) : 459 - 465
  • [37] Multiple Myeloma Relapse Following Autologous Stem Cell Transplant Presenting With Diffuse Pulmonary Nodules
    Sumrall, Bradley
    Diethelm, Lisa
    Brown, Archie, Jr.
    OCHSNER JOURNAL, 2013, 13 (04): : 553 - 557
  • [38] Patient-reported outcomes following autologous stem cell transplant for patients with multiple myeloma
    Biran, Noa
    Zhai, Wanting
    Jensen, Roxanne E.
    Mandelblatt, Jeanne
    Kumka, Susan
    Unawane, Rashmi
    Graves, Kristi D.
    Vesole, David H.
    Siegel, David S.
    Potosky, Arnold L.
    EJHAEM, 2021, 2 (03): : 488 - 492
  • [39] The impact of social vulnerability index on survival following autologous stem cell transplant for multiple myeloma
    Kiarash Salafian
    Christine Mazimba
    Leonid Volodin
    Indumathy Varadarajan
    Asal Pilehvari
    Wen You
    Ziyad O. Knio
    Karen Ballen
    Bone Marrow Transplantation, 2024, 59 : 459 - 465
  • [40] Prospective study of immunomodulation with GM-CSF, IL-2, and rituximab following autologous stem cell transplant (SCT) in patients with relapsed lymphomas.
    Smith, SM
    Grinblatt, DL
    Gajewski, T
    Harlin, H
    Welborne, K
    Conner, K
    Larson, RA
    Rich, E
    Odenike, O
    Zimmerman, T
    van Besien, K
    BLOOD, 2004, 104 (11) : 263A - 263A
12345